SereNeuro Therapeutics revealed promising results for SN101, a first-in-class iPSC-derived therapy designed to treat chronic osteoarthritis pain while protecting joint tissue. Instead of blocking pain ...
An international team of researchers led by scientists from the Max Planck Institute for Evolutionary Anthropology in Leipzig, working with 15 collaborators around the world, has conducted the most ...